Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
desvenlafaxine, Quantity: 100 mg
Medis Pharma Pty Ltd
Desvenlafaxine
Tablet, modified release
Excipient Ingredients: magnesium stearate; hypromellose; alginic acid; citric acid monohydrate; povidone; purified talc; microcrystalline cellulose; titanium dioxide; macrogol 8000; iron oxide red; iron oxide black
Oral
28, 7, 14
(S4) Prescription Only Medicine
For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.
Visual Identification: Dark brown to red colored, diamond shaped, biconvex tablets, debossed with 'Ll90' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2014-11-26